Our Mission

Light it up. Know it now.

Xenova is a Singapore-based high-tech diagnostics company dedicated to advancing global access to cutting-edge in vitro diagnostic (IVD) solutions powered by Light-Initiated Chemiluminescence (LICL) technology. Our mission is to make high-performance diagnostics faster, smarter, and more accessible across all levels of care.

At the heart of Xenova’s innovation is the X-Lab Mini Light-Initiated Chemiluminescent Immunoanalyzer, a compact and intelligent platform developed by an internationally recognized R&D team. This breakthrough system is built on a proprietary light-activated homogeneous reaction, enabling sample-to-result reporting within just 3 to 15 minutes—with no need for additional buffers or wash steps. Weighing only 7.5kg, the analyzer is ideally suited for decentralized settings, including point-of-care, emergency, and small-scale laboratories.

Uniquely, the platform supports whole blood testing for all parameters, covering a wide range of clinical markers such as cardiac (e.g., high-sensitivity Troponin I), inflammation, thyroid function, tumor markers, and hormones. Its use of fully homogeneous reaction technology ensures exceptionally stable assay performance, achieving coefficient of variation (CV) values as low as 5%—matching or exceeding the standards of central laboratory systems.

With lyophilized reagents that allow room temperature transport and storage, Xenova offers flexible, scalable solutions tailored for global deployment.

Headquartered in Singapore, Xenova has established a full operational structure including product registration, quality management, technical support, and international commercialization. We work in close collaboration with the original technology innovators to maintain a seamless link between R&D and global strategy, ensuring the continuous evolution of the LICL platform.